XEMBIFY 200 mg/mL

XEMBIFY 200 mg/mL is a subcutaneous immune globulin solution designed to support immune system function. This pharmaceutical product is manufactured by Grifols USA, LLC and is available in a 20 mL vial.

XEMBIFY 200 mg/mL is primarily used to treat immune deficiencies by providing essential antibodies. It is administered subcutaneously to help the body fight infections and maintain immune health. This medication is often prescribed for conditions where the immune system is compromised or not functioning properly.

Common effects of XEMBIFY 200 mg/mL may include localized reactions at the injection site, such as redness, swelling, or discomfort. Some individuals may experience systemic effects like headache, fatigue, or mild flu-like symptoms. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

XEMBIFY 200 mg/mL should be handled with care and stored as directed to maintain its efficacy. It is important to follow proper subcutaneous administration techniques to minimize the risk of infection or other complications. Patients should inform their healthcare provider about any allergies or medical conditions before using this medication.

XEMBIFY 200 mg/mL may interact with certain medications, particularly those that affect the immune system. It is advisable to consult a healthcare provider before combining this medication with other treatments. Additionally, alcohol and other substances that may impact immune function should be discussed with a healthcare professional.